by NewsDesk Laugh
A joint symposium on controlling the spread of Creutzfeldt-Jakob disease (CJD) was held with the Korea Centers for Disease Control and Prevention and the Korean Neurological Society on Saturday.
Creutzfeldt-Jakob disease (CJD) is a type of TSE (transmissible spongiform encephalopathies) or prion disease that occurs in humans and is classified into sporadic CJD, genetic CJD, iatrogenic CJD depending on the course of infection.
Creutzfeldt-Jakob disease (CJD) has an incubation period of several years to several decades, but cognitive dysfunction and neurological symptoms (visual impairment, gait disturbance, dystonia, dyskinesia, etc.) is a rapidly evolving infectious disease with high severity.
Subscribe to Outbreak News TV on YouTube
According to the Korean Centers for Disease Control, A A total of 67 cases occurred in Korea in 2021, and the trend has been gradually increasing over the past five years – 38 in 2017, 54 in 2018, 53 in 2019, 64 in 2020 and 67 in 2021.
Analysis of the number of occurrences by type as of 2021– About 85% (57 cases) of sporadic CJD (CJD, sporadic sCJD) occurred without any identifiable cause, and about 15% (10 cases) of hereditary CJD (gCJD), which are spread and occur through inheritance.
During the symposium, in-depth discussions were held on the need for preventive management in medical institutions to prevent secondary transmission of CJD, the need for autopsies of CJD patients, the role of autopsy centers, and measures to strengthen the CJD surveillance system.
Creutzfeldt-Jakob disease: A North Carolina hospital says at least 18 surgical patients have had it
Creutzfeldt-Jakob disease takes the life of Utah House spokesman Becky Lockhart
